Abstract. Nowadays nanotechnology as a new direction of science allows to develop therapeutic methods of the endogenous intoxication syndrome and to create a new class of biocompatible sorbents. In Ukraine first preparations of medical nanotechnology were produced and patented in 1998. These are "IKBB" intracorporeal biocorrector, magnet-controlled sorbent (MCS-B), and "Micromage-B". The preparations are based on colloid magnetite particles (Fe 3 O 4 ) from 6 to 12 nm. Adsorption layer provides a high sorption activity to magnetite nanoparticles. Total activity of their sorption surface is 800 -1200 m 2 /g, magnetic field intensity produced by each particle is 300 -400 kA/m, ζ -potential is -19 mV. Each magnetite particle is a subdomain elementary magnetite of a sphere shape. The main biological action of nanotechnology preparations is direct to regulation of cell metabolism. Therapeutic effect of this preparation is based on the influence of adsorption process and of constant magnetic field that surrounds colloid magnetite particle on cellular and subcellular structures. Point of attack is surface proteins of cell membranes. Colloid magnetite particles modify composition of protein molecules thereby effecting transport of substances to a cell. Using magnet-controlled sorbent the method of extracorporal hemocorrection on the whole is rather the method of effective and reliable way to activate natural processes of detoxication of organism, than the method of artificial detoxication. The absence of contra-indication and incidental effects (haematic, haemodynamic, hormone, electrolytic, immune) creates real predisposition for using this method in intensive therapy of intoxication syndrome.
Introdaction.
In Ukraine first preparations of medical nanotechnology were produced and patented in 1998. These are IKBB (intracorporal biocorrector), magnet-controlled sorbent brand of MCS-B, and Micromage-B [1, 2] . The preparations are based on colloid magnetite particles (Fe 3 O 4 ) from 6 to 12 nm. Adsorption layer provides a high sorption activity to magnetite nanoparticles. Total activity of their sorption surface is 800 -1200 m 2 /g, magnetic field intensity produced by each particle is 300 -400 kA/m and ζ -potential is -19 mV. Extracorporal hemocorrection method with application of magnet-controlled sorbent (MCS-B) has a significant pathogenetic advantage over the existing detoxication methods [3] .
Experimental resuts and discussions.
The reliable was established sorption activity of magnetite nanoparticles regarding heavy metal salts, nitrates, phenol, and passivity regarding the main electrolytes of blood plasma. This allows using magnet-controlled sorbent MCS-B for cleaning biological body liquids without a threat of electrolytic disorder. It is also important to mention that magnet-controlled sorbent has not only a sorption effect but also an indirect effect caused by the influence of a constant magnetic field created by magnetite nanoparticles. An important advantage of magnet-controlled sorbent MCS-B is that its sorption qualities are highly specific (selective) and that they have a big resemblance with molecular components of blood plasma which stimulate endogenous intoxication syndrome.
Such selectivity of magnet-controlled sorbent creates prerequisites for indirect sanogenetic effects in the process of therapy. A particular characteristic of the extracorporal hemocorrection method with application of magnetcontrolled sorbent is that, first of all this method is an alternative not to a detoxication method but to a systemic nonspecific biological modulation. The presence of a constant magnetic field around magnetite nanoparticles allows magnet-controlled sorbent to not only perform a selective adsorption of various substances like it is in magnetic phoresis, but also to actively effect intracellular biochemical processes. Activating the process of oxyhemoglobin dissociation up to 1.5-2 times and raising output of blood oxygen to tissues, magnet-controlled sorbent restores bioelectric potential of erythrocyte membranes, improves operation of blood cells, normalizes rheology and microcirculation ( fig.1, 2) . Causing changes in hemoglobin buffer system, magnet-controlled sorbent exhaustively corrects pH and alkaline reserve of venous blood. Improvement of metabolic disorders at cell level has been confirmed by results of electron microscope examination of the organs of reticuloendothelial system (liver, kidneys, lungs) in experiment.
Restoration of metabolic shifts of homeostasis, of physical and chemical characteristics of tissue structures, of balance between antiradical and proradical products characterizes a direct effect of magnet-controlled sorbent on free radical oxidation of lipids. This fact predetermines the main pathogenetic difference of the offered method from the other types of intensive therapy. Correction of balance between antiradical and proradical products provides activity of magnetcontrolled sorbent regarding pathogenic germs and condition of cellular immunity. As a result sensitivity of pathogenic germs (Staphylococcus aureus, Pseudomonas aeruginosa, Corynebacterium diphtheria, fungi of Candida type) to antibiotics increases in 2-3 times, and arises a pronounced bacteriostatic effect regarding pathogenic microflora. At the same time, MCS-B nanoparticles do not cause changes of biological characteristics of normal flora with exception of short term slight inhibition of growth qualities. Selective bacteriostatic and antifungal effects, correction of immunologic disorder (increase in phagocytic activity of leucocytes and in phagocytosis completeness index, liquidation of immunoregulatory cells disbalance) complete the list of biological effects of magnet-controlled sorbent nanoparticles. The principle of magnetic phoresis allows magnet-controlled sorbent nanoparticles to restore indices of protein ( fig.3 ) and lipid blood fractions, to improve albumin-globulin coefficient, ESR, the level of lipid peroxidation products, regulate the quantity of hormones, of circulating immune complexes, and of microlymphocytotoxicity autoantibody.
Conclusion.
The proposed method of using MСS-B nanoparticles is technically simple and reliable in action. Absence of side effects (haemic, hemodynamic, electrolytic, hormonal, protein, lipid, immunological) creates real prerequisites for using this method in intensive therapy of patients with clinical cases of endogenous intoxication syndrome. The method can be used in the cases when the other methods of artificial detoxication are contraindicated (anaemia, hypoproteinemia, coagulopathy, thrombocytopenia) [5] . 
